Clinical Trial Update: Application Study of 68Ga-NOTA-BCMA Nanoantibody Imaging in Multiple Myeloma [NA]

View source ↗

Summary

An application study evaluating 68Ga-NOTA-BCMA nanoantibody imaging for multiple myeloma is described; the trial is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• 68Ga-NOTA-BCMA Nanoantibody

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Multiple Myeloma (MM) | NA | Status: NOT_YET_RECRUITING